Google Ads healthcare policy mapped to GLP-1 telehealth ad lines

The Google Ads healthcare policy (Healthcare and medicines) allows drug names like semaglutide in US ad text, but telehealth brands need certification to promote prescription services or bid on those terms. Offering prescription drugs without a prescription is egregious. Supplements can’t claim to work like prescription drugs, and drug-term ads can’t use Customer Match or lookalikes.

Policy checked on October 26, 2026.

What Google’s healthcare and medicines policy says

Google’s healthcare policy sets its rules by product and by location. For the US, Restricted drug terms says:

“You may use prescription drug terms for promotional purposes, in accordance with local laws and regulations.” (Google Ads, Restricted drug terms, US section, checked October 26, 2026)

Keyword-targeting the terms needs certification, and so do “telemedicine providers” as a business type. The steps are in Google telemedicine certification. Google names LegitScript as the accreditation it accepts for US telemedicine; what that involves for a GLP-1 brand is in LegitScript certification.

The Google rules a GLP-1 campaign touches

A GLP-1 telehealth campaign falls under 3 Google policies: Healthcare and medicines, Personalized advertising and Misrepresentation.

Sample GLP-1 ad lines and the Google rule each one triggers

Each line below is a sample we wrote, not a real ad from any brand.

Google’s Health category lists “Treatments for chronic health conditions like diabetes or arthritis” but doesn’t name weight loss or obesity. We test GLP-1 lines against rules like these before they run on Meta, Outbrain and TikTok.

Why drug-term ads lose Customer Match and lookalikes

Google treats Restricted drug terms as a sensitive interest category, so ads promoting prescription drugs can’t use Customer Match, Your data segments, Audience expansion or Lookalike segments.

Predefined Google audiences still work: In-market segments, Affinity, Life events, Demographics and location targeting. Custom segments with sensitive creative “only serve with Display campaigns to non-sensitive audiences or contextually.” Meta’s equivalent for health sites is in Meta health data restrictions.

How Google enforces the healthcare policy

Google’s healthcare enforcement depends on the rule: a warning first for drug-term and prescription-service violations, none for unauthorized pharmacies.

Google says it “blocked or removed over 8.3 billion ads and suspended 24.9 million accounts” in 2025 (Ads Safety Report, April 16, 2026). After a warning, fix the flagged ads within the 7 days, or appeal from the account if Google got it wrong.

Change log, US view:

• October 14, 2025: the US drug-term rules above, enforced from October 29, 2025 and “ramping up over approximately 4-6 weeks.”
• April 7 and July 22, 2026: New Zealand, India and Spain only.
• No US healthcare policy change posted since October 2025, as of October 26, 2026.

FAQ

Does Google ban weight-loss ads?

No policy page we read bans them. The limits come from Unapproved substances, Misrepresentation and the personalized-ads categories.

Can I advertise compounded semaglutide on Google?

Google’s healthcare page has no compounding-specific rule, so the rules above apply as they do to any GLP-1 offer. FDA’s limits on compounded drug claims still govern what the ad may say.